This is the authors' abstract. We don't add key points for this paper.
Currently available diagnostic tests for Clostridioides difficile infection (CDI) lack specificity or sensitivity, which has led to guideline recommendations for multistep testing algorithms. Ultrasensitive assays for detection of C. difficile toxins provide measurements of disease-specific markers at very low concentrations. These assays may show improved accuracy compared to that of current testing methods and offer a potential standalone solution for CDI diagnosis, although large studies of clinical performance and accuracy are lacking.
Answers are grounded in this paper and cite their sources.
No takes yet. Share an insight, caveat, or question.
Sandlund et al. (2020) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: